Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2015) 474 N.R. 311 (FCA)
Linked as:
Extract
Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2015) 474 N.R. 311 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Novartis Pharmaceuticals Canada Inc. v. Cobalt Pharmaceuticals Co. et al., (2014) 459 N.R. 17 (FCA)
- AbbVie Corp. v. Janssen Inc., [2014] F.T.R. Uned. 23 (FC)
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2012) 432 N.R. 292 (FCA)
- Wenzel Downhole Tools Ltd. et al. v. National-Oilwell Canada Ltd. et al., (2012) 443 N.R. 173 (FCA)